001     137126
005     20250321142424.0
024 7 _ |a 10.1007/s00401-013-1189-3
|2 doi
024 7 _ |a pmid:24132570
|2 pmid
024 7 _ |a 0001-6322
|2 ISSN
024 7 _ |a 1432-0533
|2 ISSN
024 7 _ |a altmetric:32580480
|2 altmetric
037 _ _ |a DZNE-2020-03448
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Mori, Kohji
|b 0
245 _ _ |a Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins.
260 _ _ |a Heidelberg
|c 2013
|b Springer
264 _ 1 |3 online
|2 Crossref
|b Springer Science and Business Media LLC
|c 2013-10-17
264 _ 1 |3 print
|2 Crossref
|b Springer Science and Business Media LLC
|c 2013-12-01
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1742563425_25225
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Massive GGGGCC repeat expansion in the first intron of the gene C9orf72 is the most common known cause of familial frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS). Despite its intronic localization and lack of an ATG start codon, the repeat region is translated in all three reading frames into aggregating dipeptide-repeat (DPR) proteins, poly-(Gly-Ala), poly-(Gly-Pro) and poly-(Gly-Arg). We took an antibody-based approach to further validate the translation of DPR proteins. To test whether the antisense repeat RNA transcript is also translated, we raised antibodies against the predicted products, poly-(Ala-Pro) and poly-(Pro-Arg). Both antibodies stained p62-positive neuronal cytoplasmic inclusions throughout the cerebellum and hippocampus indicating that not only sense but also antisense strand repeats are translated into DPR proteins in the absence of ATG start codons. Protein products of both strands co-aggregate suggesting concurrent translation of both strands. Moreover, an antibody targeting the putative carboxyl terminus of DPR proteins can detect inclusion pathology in C9orf72 repeat expansion carriers suggesting that the non-ATG translation continues through the entire repeat and beyond. A highly sensitive monoclonal antibody against poly-(Gly-Arg), visualized abundant inclusion pathology in all cortical regions and some inclusions also in motoneurons. Together, our data show that the GGGGCC repeat is bidirectionally translated into five distinct DPR proteins that co-aggregate in the characteristic p62-positive TDP-43 negative inclusions found in FTLD/ALS cases with C9orf72 repeat expansion. Novel monoclonal antibodies against poly-(Gly-Arg) will facilitate pathological diagnosis of C9orf72 FTLD/ALS.
536 _ _ |a 342 - Disease Mechanisms and Model Systems (POF3-342)
|0 G:(DE-HGF)POF3-342
|c POF3-342
|f POF III
|x 0
536 _ _ |a 344 - Clinical and Health Care Research (POF3-344)
|0 G:(DE-HGF)POF3-344
|c POF3-344
|f POF III
|x 1
542 _ _ |i 2013-10-17
|2 Crossref
|u http://www.springer.com/tdm
588 _ _ |a Dataset connected to CrossRef, PubMed,
650 _ 7 |a C9orf72 Protein
|2 NLM Chemicals
650 _ 7 |a C9orf72 protein, human
|2 NLM Chemicals
650 _ 7 |a Proteins
|2 NLM Chemicals
650 _ 2 |a Amyotrophic Lateral Sclerosis: diagnosis
|2 MeSH
650 _ 2 |a Amyotrophic Lateral Sclerosis: genetics
|2 MeSH
650 _ 2 |a Amyotrophic Lateral Sclerosis: metabolism
|2 MeSH
650 _ 2 |a Brain: metabolism
|2 MeSH
650 _ 2 |a C9orf72 Protein
|2 MeSH
650 _ 2 |a DNA Repeat Expansion
|2 MeSH
650 _ 2 |a Frontotemporal Lobar Degeneration: diagnosis
|2 MeSH
650 _ 2 |a Frontotemporal Lobar Degeneration: genetics
|2 MeSH
650 _ 2 |a Frontotemporal Lobar Degeneration: metabolism
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Protein Biosynthesis
|2 MeSH
650 _ 2 |a Proteins: genetics
|2 MeSH
650 _ 2 |a Proteins: metabolism
|2 MeSH
700 1 _ |a Arzberger, Thomas
|0 P:(DE-2719)2811333
|b 1
|u dzne
700 1 _ |a Grässer, Friedrich A
|b 2
700 1 _ |a Gijselinck, Ilse
|b 3
700 1 _ |a May, Stephanie
|0 P:(DE-2719)2762699
|b 4
|u dzne
700 1 _ |a Rentzsch, Kristin
|0 P:(DE-2719)2501892
|b 5
|u dzne
700 1 _ |a Weng, Shih-Ming
|0 P:(DE-2719)9000401
|b 6
|u dzne
700 1 _ |a Schludi, Martin H
|0 P:(DE-2719)2810746
|b 7
|u dzne
700 1 _ |a van der Zee, Julie
|b 8
700 1 _ |a Cruts, Marc
|b 9
700 1 _ |a Van Broeckhoven, Christine
|b 10
700 1 _ |a Kremmer, Elisabeth
|0 P:(DE-2719)9000167
|b 11
|u dzne
700 1 _ |a Kretzschmar, Hans A
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Haass, Christian
|0 P:(DE-2719)2202037
|b 13
|e Corresponding author
|u dzne
700 1 _ |a Edbauer, Dieter
|0 P:(DE-2719)2231621
|b 14
|e Last author
|u dzne
773 1 8 |a 10.1007/s00401-013-1189-3
|b : Springer Science and Business Media LLC, 2013-10-17
|n 6
|p 881-893
|3 journal-article
|2 Crossref
|t Acta Neuropathologica
|v 126
|y 2013
|x 0001-6322
773 _ _ |a 10.1007/s00401-013-1189-3
|g Vol. 126, no. 6, p. 881 - 893
|0 PERI:(DE-600)1458410-4
|n 6
|q 126:6<881 - 893
|p 881-893
|t Acta neuropathologica
|v 126
|y 2013
|x 0001-6322
856 4 _ |u https://pub.dzne.de/record/137126/files/DZNE-2020-03448_Restricted.pdf
856 4 _ |u https://pub.dzne.de/record/137126/files/DZNE-2020-03448_Restricted.pdf?subformat=pdfa
|x pdfa
909 C O |p VDB
|o oai:pub.dzne.de:137126
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2811333
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2762699
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2501892
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9000401
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)2810746
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 11
|6 P:(DE-2719)9000167
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)2202037
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2231621
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-342
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms and Model Systems
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Erkrankungen des Nervensystems
|1 G:(DE-HGF)POF3-340
|0 G:(DE-HGF)POF3-344
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2013
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACTA NEUROPATHOL : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b ACTA NEUROPATHOL : 2017
920 1 _ |0 I:(DE-2719)1111016
|k AG Levin
|l Clinical Neurodegeneration
|x 0
920 1 _ |0 I:(DE-2719)1110004
|k AG Edbauer
|l Cell Biology of Neurodegeneration
|x 1
920 1 _ |0 I:(DE-2719)5000050
|k Ext HZM
|l Ext HZM
|x 2
920 1 _ |0 I:(DE-2719)1110007
|k AG Haass
|l Molecular Neurodegeneration
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1111016
980 _ _ |a I:(DE-2719)1110004
980 _ _ |a I:(DE-2719)5000050
980 _ _ |a I:(DE-2719)1110007
980 _ _ |a UNRESTRICTED
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-011-0911-2
|2 Crossref
|o 10.1007/s00401-011-0911-2
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2013.02.004
|2 Crossref
|o 10.1016/j.neuron.2013.02.004
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.ajhg.2013.01.011
|2 Crossref
|o 10.1016/j.ajhg.2013.01.011
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1440-1789.2012.01332.x
|2 Crossref
|o 10.1111/j.1440-1789.2012.01332.x
999 C 5 |9 -- missing cx lookup --
|a 10.1136/jnnp.2009.204081
|2 Crossref
|o 10.1136/jnnp.2009.204081
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.tins.2013.04.010
|2 Crossref
|o 10.1016/j.tins.2013.04.010
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2011.09.011
|2 Crossref
|o 10.1016/j.neuron.2011.09.011
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.cell.2012.02.022
|2 Crossref
|o 10.1016/j.cell.2012.02.022
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-013-1147-0
|2 Crossref
|o 10.1007/s00401-013-1147-0
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(11)70261-7
|2 Crossref
|o 10.1016/S1474-4422(11)70261-7
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.virol.2009.11.023
|2 Crossref
|o 10.1016/j.virol.2009.11.023
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.febslet.2008.07.027
|2 Crossref
|o 10.1016/j.febslet.2008.07.027
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-011-0839-6
|2 Crossref
|o 10.1007/s00401-011-0839-6
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1440-1789.2008.00966.x
|2 Crossref
|o 10.1111/j.1440-1789.2008.00966.x
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/aws357
|2 Crossref
|o 10.1093/brain/aws357
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(10)70195-2
|2 Crossref
|o 10.1016/S1474-4422(10)70195-2
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/awr361
|2 Crossref
|o 10.1093/brain/awr361
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-013-1088-7
|2 Crossref
|o 10.1007/s00401-013-1088-7
999 C 5 |9 -- missing cx lookup --
|a 10.1126/science.1232927
|2 Crossref
|o 10.1126/science.1232927
999 C 5 |9 -- missing cx lookup --
|a 10.1007/s00401-008-0477-9
|2 Crossref
|o 10.1007/s00401-008-0477-9
999 C 5 |y 1989
|2 Crossref
|o DS Peabody 1989
999 C 5 |9 -- missing cx lookup --
|a 10.1371/journal.pgen.1002018
|2 Crossref
|o 10.1371/journal.pgen.1002018
999 C 5 |9 -- missing cx lookup --
|a 10.1111/j.1440-1789.2009.01043.x
|2 Crossref
|o 10.1111/j.1440-1789.2009.01043.x
999 C 5 |9 -- missing cx lookup --
|a 10.1038/nrneurol.2012.117
|2 Crossref
|o 10.1038/nrneurol.2012.117
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2011.09.010
|2 Crossref
|o 10.1016/j.neuron.2011.09.010
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.neuron.2013.03.026
|2 Crossref
|o 10.1016/j.neuron.2013.03.026
999 C 5 |9 -- missing cx lookup --
|a 10.1016/S1474-4422(13)70210-2
|2 Crossref
|o 10.1016/S1474-4422(13)70210-2
999 C 5 |9 -- missing cx lookup --
|a 10.1002/humu.22244
|2 Crossref
|o 10.1002/humu.22244
999 C 5 |9 -- missing cx lookup --
|a 10.1212/01.wnl.0000327523.52537.86
|2 Crossref
|o 10.1212/01.wnl.0000327523.52537.86
999 C 5 |9 -- missing cx lookup --
|a 10.3109/07853890.2012.665471
|2 Crossref
|o 10.3109/07853890.2012.665471
999 C 5 |9 -- missing cx lookup --
|a 10.1093/brain/aws001
|2 Crossref
|o 10.1093/brain/aws001
999 C 5 |9 -- missing cx lookup --
|a 10.1016/j.ajhg.2013.04.017
|2 Crossref
|o 10.1016/j.ajhg.2013.04.017
999 C 5 |9 -- missing cx lookup --
|a 10.2353/ajpath.2007.060576
|2 Crossref
|o 10.2353/ajpath.2007.060576
999 C 5 |9 -- missing cx lookup --
|a 10.1073/pnas.1013343108
|2 Crossref
|o 10.1073/pnas.1013343108


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21